Cargando…

Serum biomarker panel for disease severity and prognosis in patients with COVID‐19

BACKGROUND: Coronavirus disease‐2019 (COVID‐19) has become a worldwide emergency and has had a severe impact on human health. Inflammatory factors have the potential to either enhance the efficiency of host immune responses or damage the host organs with immune overreaction in COVID‐19. Therefore, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing, Tang, Mingyang, Liu, Didi, Xie, Zongyu, Wang, Fengchao, Yang, Yanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937873/ https://www.ncbi.nlm.nih.gov/pubmed/36604799 http://dx.doi.org/10.1002/jcla.24831

Ejemplares similares

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19
por: Abbas, Amal A., et al.
Publicado: (2022)

Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019
por: Sun, Jia-Kui, et al.
Publicado: (2020)

Serum biomarker panels for diagnosis of gastric cancer
por: Tong, Weihua, et al.
Publicado: (2016)

Serum biomarker panels for the diagnosis of gastric cancer
por: Wu, Dan, et al.
Publicado: (2019)

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
por: Oikonomopoulou, K, et al.
Publicado: (2008)

Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19
por: Chen, Qianqian, et al.
Publicado: (2020)

Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis
por: Pieri, Massimo, et al.
Publicado: (2021)

Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis
por: Li, Huan, et al.
Publicado: (2020)

Serum calprotectin as a novel biomarker for severity of COVID-19 disease
por: Kaya, Tezcan, et al.
Publicado: (2021)

Serum biomarker panel for the diagnosis of rheumatoid arthritis
por: Mun, Sora, et al.
Publicado: (2021)

Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms
por: Kimawaha, Phongsaran, et al.
Publicado: (2021)

Identification of biomarker panels as predictors of severity in coronary artery disease
por: Ben Braiek, Assia, et al.
Publicado: (2020)

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
por: Shaw, Victoria E, et al.
Publicado: (2014)

Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients
por: Guo, Hui, et al.
Publicado: (2020)

Evaluation of a Serum Lung Cancer Biomarker Panel
por: Mazzone, Peter J, et al.
Publicado: (2018)

A Novel Panel of Serum Biomarkers for MPM Diagnosis
por: Bonotti, A., et al.
Publicado: (2017)

Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease
por: Zeng, Yuping, et al.
Publicado: (2022)

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
por: Craig-Schapiro, Rebecca, et al.
Publicado: (2011)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

A Panel of Serum MiRNA Biomarkers for the Diagnosis of Severe to Mild Traumatic Brain Injury in Humans
por: Bhomia, Manish, et al.
Publicado: (2016)

Evaluation of serum procalcitonin level as a biomarker for disease severity in COVID-19 patients
por: Waris, A., et al.
Publicado: (2021)

Serum Level of 4-Hydroxynonenal in Community-Acquired Pneumonia: A Potential Biomarker for Severity and Prognosis
por: Jiang, Ya-Lin, et al.
Publicado: (2022)

Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma
por: Firpo, Matthew A., et al.
Publicado: (2023)

A serum metabolic biomarker panel for early rheumatoid arthritis
por: Rodríguez-Muguruza, Samantha, et al.
Publicado: (2023)

Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications
por: Chen, Chuang, et al.
Publicado: (2014)

Endoplasmic Reticulum Stress-Regulated Chaperones as a Serum Biomarker Panel for Parkinson’s Disease
por: Mnich, Katarzyna, et al.
Publicado: (2022)

The Impact of Serum Levels of Vitamin D3 and Its Metabolites on the Prognosis and Disease Severity of COVID-19
por: Khojah, Hani M. J., et al.
Publicado: (2022)

Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients
por: Tang, Jinsong, et al.
Publicado: (2021)

ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease
por: Skarstein Kolberg, Espen
Publicado: (2020)

Serum‐derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID‐19 patients
por: Tertel, Tobias, et al.
Publicado: (2022)

IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
por: Chen, Yu, et al.
Publicado: (2020)

Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma
por: Lv, Shaogang, et al.
Publicado: (2017)

A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
por: Yanagawa, Hiroyuki, et al.
Publicado: (2014)

Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020
por: Sun, Hong, et al.
Publicado: (2020)

Auxiliary diagnosis of Lung Cancer on the basis of a Serum Protein Biomarker Panel
por: Lu, Qiong, et al.
Publicado: (2021)

A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study
por: Wang, Ziyue, et al.
Publicado: (2022)

Diagnostic biomarker panels of osteoarthritis: UPLC-QToF/MS-based serum metabolic profiling
por: Lin, Xinxin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gf6aofkjq0fosbvc3vkvm1elcv